Midostaurin and Dyspnea exacerbated - a phase IV clinical study of FDA data

Summary:

Dyspnea exacerbated is reported as a side effect among people who take Midostaurin (midostaurin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Rivaroxaban, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Dyspnea exacerbated when taking Midostaurin. It is created by eHealthMe based on reports of 1,137 people who have side effects when taking Midostaurin from the FDA, and is updated regularly.

What is Midostaurin?

Midostaurin has active ingredients of midostaurin. eHealthMe is studying from 1,137 Midostaurin users. Check the latest studies of Midostaurin.

What is Dyspnea exacerbated?

Dyspnea exacerbated is found to be associated with 3,311 drugs and 1,659 conditions by eHealthMe. Check the latest studies of Dyspnea exacerbated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

1,137 people reported to have side effects when taking Midostaurin.
Among them, 23 people (2.02%) have Dyspnea exacerbated.

Could Midostaurin cause Dyspnea exacerbated?

Among these 23 people:

How long have people been on Midostaurin when they have Dyspnea exacerbated? *

What is the gender of people who have Dyspnea exacerbated when taking Midostaurin? *

female: 50 %
male: 50 %

What is the age of people who have Dyspnea exacerbated when taking Midostaurin? *

What are other drugs people take besides Midostaurin? *

What are other side effects people have besides Dyspnea exacerbated? *

Fatigue (feeling of tiredness): 7 people, 30.43%
Oedema Peripheral (superficial swelling): 6 people, 26.09%
Fever: 6 people, 26.09%
Nausea (feeling of having an urge to vomit): 5 people, 21.74%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 5 people, 21.74%
Ejection Fraction Decreased (systolic heart failure): 5 people, 21.74%
Ascites (accumulation of fluid in the abdominal cavity): 4 people, 17.39%
Interstitial Lung Disease: 4 people, 17.39%
Fainting (loss of consciousness and postural tone): 4 people, 17.39%
Febrile Neutropenia (fever with reduced white blood cells): 4 people, 17.39%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 12 people, 52.17%
Systemic Mastocytosis (a condition caused by the accumulation of mast cells in more than one part of the body): 5 people, 21.74%
Urticaria Pigmentosa (skin disease that produces patches of darker skin (lesions) and very bad itching): 3 people, 13.04%
Stress And Anxiety: 1 person, 4.35%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 4.35%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 4.35%
Pain: 1 person, 4.35%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 1 person, 4.35%
Nausea And Vomiting: 1 person, 4.35%
Urination - Excessive Volume: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Midostaurin and have Dyspnea exacerbated?

- Check whether Dyspnea exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Midostaurin:

Midostaurin (1,137 reports)

Browse all side effects of Midostaurin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (3,312 drugs)

Browse all the conditions that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (1,659 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on midostaurin (the active ingredients of Midostaurin) and Midostaurin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.